Jane Street’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-34,700
| Closed | -$4.01M | – | 10122 |
|
|
2023
Q3 | $4.01M | Sell |
34,700
-425,300
| -92% | -$45.7M | ﹤0.01% | 2933 |
|
|
2023
Q2 | $47.3M | Buy |
460,000
+386,000
| +522% | +$40.7M | 0.02% | 619 |
|
|
2023
Q1 | $8.08M | Sell |
74,000
-235,500
| -76% | -$26M | ﹤0.01% | 1859 |
|
|
2022
Q4 | $35.2M | Buy |
309,500
+232,300
| +301% | +$19.3M | 0.02% | 683 |
|
|
2022
Q3 | $4.78M | Sell |
77,200
-10,700
| -12% | -$748K | ﹤0.01% | 2703 |
|
|
2022
Q2 | $7.01M | Buy |
87,900
+9,500
| +12% | +$900K | ﹤0.01% | 2178 |
|
|
2022
Q1 | $8.25M | Sell |
78,400
-17,400
| -18% | -$1.7M | ﹤0.01% | 2246 |
|
|
2021
Q4 | $10.3M | Buy |
95,800
+33,800
| +55% | +$3.69M | ﹤0.01% | 1848 |
|
|
2021
Q3 | $6.79M | Sell |
62,000
-9,100
| -13% | -$945K | ﹤0.01% | 2304 |
|
|
2021
Q2 | $6.66M | Sell |
71,100
-280,500
| -80% | -$25.8M | ﹤0.01% | 2236 |
|
|
2021
Q1 | $32.4M | Buy |
351,600
+115,700
| +49% | +$9.76M | 0.02% | 659 |
|
|
2020
Q4 | $17.3M | Buy |
235,900
+19,900
| +9% | +$1.48M | 0.01% | 963 |
|
|
2020
Q3 | $16.8M | Buy |
216,000
+168,500
| +355% | +$11.6M | 0.01% | 870 |
|
|
2020
Q2 | $2.64M | Buy |
+47,500
| New | +$2.03M | ﹤0.01% | 2677 |
|
|
2018
Q2 | – | Sell |
-16,300
| Closed | -$231K | – | 5962 |
|
|
2018
Q1 | $231K | Buy |
+16,300
| New | +$241K | ﹤0.01% | 4307 |
|
|
2017
Q4 | – | Sell |
-12,600
| Closed | -$160K | – | 5478 |
|
|
2017
Q3 | $160K | Buy |
+12,600
| New | +$160K | ﹤0.01% | 4186 |
|
|
2017
Q2 | – | Sell |
-27,000
| Closed | -$399K | – | 5151 |
|
|
2017
Q1 | $399K | Sell |
27,000
-111,800
| -81% | -$1.81M | ﹤0.01% | 3114 |
|
|
2016
Q4 | $2.25M | Buy |
+138,800
| New | +$2.52M | 0.01% | 1212 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$165K | – | 4790 |
|
|
2016
Q2 | $165K | Buy |
+10,000
| New | +$162K | ﹤0.01% | 3807 |
|
|
2015
Q4 | – | Sell |
-51,300
| Closed | -$1.02M | – | 4687 |
|
|
2015
Q3 | $1.02M | Buy |
+51,300
| New | +$1.62M | 0.01% | 1622 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Jane Street's HZNP Position: Q4 2023 in Review
Jane Street sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 13,042 shares — an estimated $1.51M sold.
Jane Street first reported a position in HZNP in Q4 2013 and held it in 30 quarters. The position peaked at $29.2M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Jane Street reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 13,042 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.51M.
- Jane Street first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 30 quarters.
- Jane Street's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $29.2M in Q3 2020.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.